Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025
Palatin Technologies (NYSE American: PTN) has announced it will release its second quarter fiscal year 2025 operating results on Thursday, February 13, 2025, before U.S. markets open. The company will host a conference call and audio webcast at 11:00 a.m. ET the same day, featuring executive management's review of operating results and development program updates.
The earnings release is scheduled for 7:30 a.m. ET, with the live conference call following at 11:00 a.m. ET. A replay will be available from February 13-27, 2025. Palatin is a biopharmaceutical company focused on developing first-in-class medicines based on melanocortin receptor systems for diseases with unmet medical needs.
Palatin Technologies (NYSE American: PTN) ha annunciato che rilascerà i suoi risultati operativi del secondo trimestre dell'anno fiscale 2025 giovedì 13 febbraio 2025, prima dell'apertura dei mercati statunitensi. L'azienda ospiterà una conference call e un webcast audio alle 11:00 a.m. ET lo stesso giorno, con la revisione dei risultati operativi da parte del management esecutivo e aggiornamenti sui programmi di sviluppo.
Il rilascio degli utili è previsto per le 7:30 a.m. ET, con la conference call in diretta che seguirà alle 11:00 a.m. ET. Una registrazione sarà disponibile dal 13 al 27 febbraio 2025. Palatin è un'azienda biofarmaceutica focalizzata sulla sviluppo di farmaci innovativi basati sui sistemi di recettori melanocortinici per malattie con bisogni medici non soddisfatti.
Palatin Technologies (NYSE American: PTN) ha anunciado que publicará sus resultados operativos del segundo trimestre del año fiscal 2025 el jueves 13 de febrero de 2025, antes de la apertura de los mercados en EE. UU. La compañía llevará a cabo una conferencia telefónica y un webcast de audio a las 11:00 a.m. ET el mismo día, con la revisión de los resultados operativos y actualizaciones de los programas de desarrollo por parte de la alta dirección.
El anuncio de resultados está programado para las 7:30 a.m. ET, con la conferencia telefónica en vivo que seguirá a las 11:00 a.m. ET. Una grabación estará disponible del 13 al 27 de febrero de 2025. Palatin es una empresa biofarmacéutica centrada en el desarrollo de medicamentos de primera clase basados en sistemas de receptores melanocortínicos para enfermedades con necesidades médicas no satisfechas.
Palatin Technologies (NYSE American: PTN)는 2025 회계연도 2분기 운영 성과를 2025년 2월 13일 목요일, 미국 시장 개장 전에 발표한다고 전했습니다. 회사는 같은 날 오전 11시에 경영진의 운영 성과 검토 및 개발 프로그램 업데이트를 제공하는 전화 회의 및 오디오 웹캐스트를 진행할 예정입니다.
실적 발표는 오전 7시 30분에 예정되어 있으며, 생중계 전화 회의는 오전 11시에 진행됩니다. 2025년 2월 13일부터 27일까지 리플레이가 가능합니다. Palatin은 충족되지 않은 의학적 필요에 대한 멜라노코르틴 수용체 시스템을 기반으로 한 일급 약물 개발에 중점을 둔 생물제약 회사입니다.
Palatin Technologies (NYSE American: PTN) a annoncé qu'il publiera ses résultats d'exploitation du deuxième trimestre de l'exercice 2025 le jeudi 13 février 2025, avant l'ouverture des marchés américains. L'entreprise organisera une conférence téléphonique et un webinaire audio le même jour à 11h00 ET, au cours de laquelle la direction examinera les résultats d'exploitation et mettra à jour les programmes de développement.
La publication des résultats est prévue pour 7h30 ET, suivie de la conférence téléphonique en direct à 11h00 ET. Un replay sera disponible du 13 au 27 février 2025. Palatin est une entreprise biopharmaceutique axée sur le développement de médicaments de première classe basés sur des systèmes de récepteurs melanocortiniques pour des maladies ayant des besoins médicaux non satisfaits.
Palatin Technologies (NYSE American: PTN) hat angekündigt, dass es seine Operativen Ergebnisse des zweiten Quartals des Geschäftsjahres 2025 am Donnerstag, den 13. Februar 2025, vor der Eröffnung der US-Märkte veröffentlichen wird. Das Unternehmen wird am selben Tag um 11:00 Uhr ET eine Telefonkonferenz und einen Audio-Webcast veranstalten, in dem das Management die Betriebsergebnisse sowie Updates zu den Entwicklungsprogrammen überprüfen wird.
Die Veröffentlichung der Ergebnisse ist für 7:30 Uhr ET geplant, gefolgt von der Live-Telefonkonferenz um 11:00 Uhr ET. Eine Aufzeichnung wird vom 13. bis 27. Februar 2025 verfügbar sein. Palatin ist ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung von erstklassigen Arzneimitteln auf Basis von Melanocortin-Rezeptorsystemen für Krankheiten mit unerfülltem medizinischem Bedarf konzentriert.
- None.
- None.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 13, 2025, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast | |
Q2 Fiscal Year 2025 Results Press Release | 02/13/2025 at 7:30 a.m. ET |
Q2 Fiscal Year 2025 Conference Call-Live | 02/13/2025 at 11:00 a.m. ET |
US Toll Free Dial-In Number: | 1-888-506-0062 |
International Dial-In Number: | 1-973-528-0011 |
Participant Access Code: | 882092 |
Q2 Fiscal Year 2025 Conference Call-Replay | 02/13/2025-02/27/2025 |
US Toll Free Dial-In Number: | 1-877-481-4010 |
International Dial-In Number: | 1-919-882-2331 |
Participant Access Code: | 52016 |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-second-quarter-fiscal-year-2025-results-teleconference-and-webcast-to-be-held-on-february-13-2025-302372745.html
SOURCE Palatin Technologies, Inc.
FAQ
When will Palatin Technologies (PTN) release Q2 2025 earnings?
How can investors access PTN's Q2 2025 earnings call?
What is the replay information for PTN's Q2 2025 earnings call?
What will be discussed in PTN's Q2 2025 earnings call?
